Aerovate Therapeutics
Patents, Design & Utilities

Last updated:

List of all Aerovate Therapeutics patents 12 in total

Status Patent
Application
Utility: INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 14 Jul 2022
Application
Utility: NEBULIZED IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 16 Jun 2022
Grant
Utility: Inhalable imatinib formulations, manufacture, and uses thereof External link
Filling date: 5 Sep 2025 Issue date: 12 Apr 2022
Grant
Utility: Inhalable imatinib formulations, manufacture, and uses thereof External link
Filling date: 5 Sep 2025 Issue date: 25 Jan 2022
Application
Utility: INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 3 Dec 2020
Application
Utility: INHALABLE FORMULATIONS FOR KINASE INHIBITION External link
Filling date: 5 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: NEBULIZED IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: INHALABLE FORMULATIONS OF IMATINIB, IMATINIB METABOLITES, IMATINIB SALTS, THEIR MANUFACTURE, AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: INHALABLE IMATINIB METABOLITE FORMULATIONS, MANUFACTURE, AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF External link
Filling date: 5 Sep 2025 Issue date: 19 Nov 2020

Showing 1 to 12 of 12 patents.